scholarly article | Q13442814 |
P50 | author | Nancy A Monteiro-Riviere | Q55948798 |
P2093 | author name string | Jim E Riviere | |
Jessica P Ryman-Rasmussen | |||
P2860 | cites work | Exposure to carbon nanotube material: assessment of nanotube cytotoxicity using human keratinocyte cells | Q23910003 |
A physiologically based pharmacokinetic model of organophosphate dermal absorption | Q23911489 | ||
Skin as a route of exposure and sensitization in chronic beryllium disease | Q23920927 | ||
Quantum dots for live cells, in vivo imaging, and diagnostics | Q24532049 | ||
Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles | Q24536032 | ||
Methods for In Vitro Percutaneous Absorption Studies IV: the Flow-Through Diffusion Cell | Q29031246 | ||
Skin penetration and distribution of polymeric nanoparticles | Q33206355 | ||
The pig as an experimental animal model of percutaneous permeation in man: qualitative and quantitative observations--an overview | Q34001797 | ||
Differences in subcellular distribution and toxicity of green and red emitting CdTe quantum dots. | Q40462539 | ||
Hydration disrupts human stratum corneum ultrastructure | Q41629649 | ||
Percutaneous absorption of parathion in vitro in porcine skin: Effects of dose, temperature, humidity, and perfusate composition on absorptive flux | Q44857504 | ||
Multi-walled carbon nanotube interactions with human epidermal keratinocytes | Q44861557 | ||
Topical penetration of piroxicam is dependent on the distribution of the local cutaneous vasculature | Q44864877 | ||
On the cyto-toxicity caused by quantum dots | Q45071344 | ||
Probing the Cytotoxicity Of Semiconductor Quantum Dots | Q46112957 | ||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | quantum dot | Q1133068 |
P304 | page(s) | 159-65 | |
P577 | publication date | 2006-05-01 | |
P1433 | published in | Toxicological Sciences | Q2446966 |
P1476 | title | Penetration of intact skin by quantum dots with diverse physicochemical properties | |
P478 | volume | 91 |
Q28386916 | A novel method to detect unlabeled inorganic nanoparticles and submicron particles in tissue by sedimentation field-flow fractionation |
Q51636282 | A quantitative study of nanoparticle skin penetration with interactive segmentation. |
Q38542491 | A review of critical factors for assessing the dermal absorption of metal oxide nanoparticles from sunscreens applied to humans, and a research strategy to address current deficiencies |
Q103043305 | A review to support the derivation of a worst-case dermal penetration value for nanoparticles |
Q38059902 | A weight of evidence approach for hazard screening of engineered nanomaterials |
Q59133696 | Anti-Candidal Activity and In Vitro Cytotoxicity Assessment of Graphene Nanoplatelets Decorated with Zinc Oxide Nanorods |
Q50328134 | Carbon Nanotropes: A Contemporary Paradigm in Drug Delivery. |
Q30401785 | Cellular heterogeneity and live cell arrays |
Q38263063 | Cellular uptake mechanisms and toxicity of quantum dots in dendritic cells |
Q34172574 | Co-administration of protein drugs with gold nanoparticles to enable percutaneous delivery |
Q46211877 | Confocal laser scanning microscopy to estimate nanoparticles' human skin penetration in vitro |
Q38939469 | Control of nanoparticle penetration into biofilms through surface design |
Q28389879 | Cutaneous exposure scenarios for engineered nanoparticles used in semiconductor fabrication: a preliminary investigation of workplace surface contamination |
Q49370039 | Dependence of Nanoparticle Toxicity on Their Physical and Chemical Properties. |
Q23921977 | Development and characterization of antibody reagents for detecting nanoparticles |
Q37547214 | Do nanomedicines require novel safety assessments to ensure their safety for long-term human use? |
Q57256015 | Emission, Transformation, and Fate of Nanoparticles in the Atmosphere |
Q57256118 | Engineered Nanomaterials: Knowledge Gaps in Fate, Exposure, Toxicity, and Future Directions |
Q30471698 | Enhancing the transdermal delivery of rigid nanoparticles using the simultaneous application of ultrasound and sodium lauryl sulfate |
Q40024022 | Evaluation of silver nanoparticle toxicity in skin in vivo and keratinocytes in vitro. |
Q35224075 | Evidence of three-level trophic transfer of quantum dots in an aquatic food chain by using bioimaging |
Q37685270 | Gene therapy oversight: lessons for nanobiotechnology |
Q58725562 | Health Concerns of Various Nanoparticles: A Review of Their in Vitro and in Vivo Toxicity |
Q37594800 | Health effects of inhaled engineered and incidental nanoparticles |
Q37729812 | In vitro and in vivo percutaneous absorption of seleno-L-methionine, an antioxidant agent, and other selenium species |
Q33513233 | In vitro cutaneous application of ISCOMs on human skin enhances delivery of hydrophobic model compounds through the stratum corneum |
Q39166434 | In vitro cytotoxicity of CdSe/ZnS quantum dots with different surface coatings to human keratinocytes HaCaT cells |
Q43280248 | In vitro translocation of quantum dots and influence of oxidative stress |
Q47723476 | In vivo analysis of dermal and systemic absorption of silver nanoparticles through healthy human skin |
Q41518057 | In vivo biodistribution and toxicity of intravesical administration of quantum dots for optical molecular imaging of bladder cancer. |
Q28290077 | In vivo skin penetration of quantum dot nanoparticles in the murine model: the effect of UVR |
Q33853867 | In vivo study of the effects of peptide-conjugated near-infrared fluorescent quantum dots on the tumorigenic and lymphatic metastatic capacities of squamous cell carcinoma cell line Tca8113 and U14. |
Q38813548 | Influence of Nanotoxicity on Human Health and Environment: The Alternative Strategies |
Q34700358 | Interaction of nanoparticles and cell-penetrating peptides with skin for transdermal drug delivery |
Q37965056 | Interactions of nanomaterials with the immune system |
Q88906071 | Intra-articular clearance of labeled dextrans from naive and arthritic rat knee joints |
Q38832707 | Intracellular ROS levels determine the apoptotic potential of keratinocyte by Quantum Dot via blockade of AKT Phosphorylation |
Q38897338 | Intracellular imaging of quantum dots, gold, and iron oxide nanoparticles with associated endocytic pathways |
Q24634740 | Lack of significant dermal penetration of titanium dioxide from sunscreen formulations containing nano- and submicron-size TiO2 particles |
Q51306137 | Mechanisms of cell uptake, inflammatory potential and protein corona effects with gold nanoparticles. |
Q37059906 | Medicinal applications of fullerenes |
Q77791988 | Metal nanomaterials: immune effects and implications of physicochemical properties on sensitization, elicitation, and exacerbation of allergic disease |
Q35128000 | Microfluidic-enabled liposomes elucidate size-dependent transdermal transport |
Q26767037 | Microneedles: A New Frontier in Nanomedicine Delivery |
Q36316896 | Migration of intradermally injected quantum dots to sentinel organs in mice |
Q35553118 | Modification of microneedles using inkjet printing. |
Q34694911 | Multiphoton microscopy of transdermal quantum dot delivery using two photon polymerization-fabricated polymer microneedles |
Q37586225 | Nanoparticle dermal absorption and toxicity: a review of the literature. |
Q37902221 | Nanoparticles and the skin--applications and limitations |
Q28394095 | Nanoparticles and their interactions with the dermal barrier |
Q37274692 | Nanoparticles for transcutaneous vaccination |
Q38483747 | Nanoparticles skin absorption: New aspects for a safety profile evaluation |
Q37880721 | Nanoparticles through the skin: managing conflicting results of inorganic and organic particles in cosmetics and pharmaceutics. |
Q38071926 | Nanoscale materials and their use in water contaminants removal-a review |
Q57379467 | Nanotechnology and Water Treatment: Applications and Emerging Opportunities |
Q34296083 | Nanotechnology in cosmetics: Opportunities and challenges |
Q28385380 | Nanotechnology in medicine and relevance to dermatology: present concepts |
Q36865560 | Nanotechnology safety concerns revisited |
Q52597834 | Nanotoxicology: a personal perspective. |
Q37835204 | Nanotoxicology: an interdisciplinary challenge |
Q28396477 | Naturally occurring nanoparticles from English ivy: an alternative to metal-based nanoparticles for UV protection |
Q92651546 | Noninvasive in vivo human multiphoton microscopy: a key method in proving nanoparticulate zinc oxide sunscreen safety |
Q23923393 | Occupational exposure to nanomedical applications |
Q26853219 | Overview about the localization of nanoparticles in tissue and cellular context by different imaging techniques |
Q23909527 | Oxidative stress and inflammatory response in dermal toxicity of single-walled carbon nanotubes |
Q38401187 | Parameters and characteristics governing cellular internalization and trans-barrier trafficking of nanostructures |
Q37530378 | Particle based vaccine formulations for transcutaneous immunization |
Q38197488 | Perturbation of physiological systems by nanoparticles. |
Q28384922 | Physicochemical factors that affect metal and metal oxide nanoparticle passage across epithelial barriers |
Q38030891 | Physiological behavior of quantum dots. |
Q33824064 | Potential photocarcinogenic effects of nanoparticle sunscreens |
Q26744195 | Potential toxicity of engineered nanoparticles in mammalian germ cells and developing embryos: treatment strategies and anticipated applications of nanoparticles in gene delivery |
Q28390527 | Quantification of quantum dot murine skin penetration with UVR barrier impairment |
Q38048694 | Quantifying and imaging engineered nanomaterials in vivo: challenges and techniques |
Q28390277 | Quantitative determination of skin penetration of PEG-coated CdSe quantum dots in dermabraded but not intact SKH-1 hairless mouse skin |
Q39438953 | Quantum dot 705, a cadmium-based nanoparticle, induces persistent inflammation and granuloma formation in the mouse lung |
Q40373640 | Quantum dot effects upon the interaction between porphyrins and phospholipids in cell membrane models |
Q33860137 | Quantum dot penetration into viable human skin |
Q24653011 | Quantum dots for live cell and in vivo imaging |
Q36163772 | Quantum dots: an insight and perspective of their biological interaction and how this relates to their relevance for clinical use. |
Q42280379 | Receptor- and ligand-based study of fullerene analogues: comprehensive computational approach including quantum-chemical, QSAR and molecular docking simulations |
Q90187112 | Risk Perceptions and Safety Cultures in the Handling of Nanomaterials in Academia and Industry |
Q36319658 | Risk assessment of nanomaterials in cosmetics: a European union perspective |
Q34131041 | Small amounts of zinc from zinc oxide particles in sunscreens applied outdoors are absorbed through human skin |
Q92282749 | Spironolactone-Loaded LeciPlexes as Potential Topical Delivery Systems for Female Acne: In Vitro Appraisal and Ex Vivo Skin Permeability Studies |
Q24656654 | State of academic knowledge on toxicity and biological fate of quantum dots |
Q92035180 | Study on intracellular delivery of liposome encapsulated quantum dots using advanced fluorescence microscopy |
Q91973095 | The Role of Nanomaterials in the Treatment of Diseases and Their Effects on the Immune System |
Q28390743 | The new toxicology of sophisticated materials: nanotoxicology and beyond |
Q50046147 | The surface chemistry determines the spatio-temporal interaction dynamics of quantum dots in atherosclerotic lesions. |
Q39431201 | Three-dimensional hydrogel constructs for exposing cells to nanoparticles |
Q46924117 | Toll-like receptor 6 mediated inflammatory and functional responses of zinc oxide nanoparticles primed macrophages |
Q38009230 | Toxico-/biokinetics of nanomaterials |
Q23914977 | Toxicology of nanomaterials used in nanomedicine |
Q81698212 | Trophic transfer of nanoparticles in a simplified invertebrate food web |
Q28382873 | Understanding the mechanism of toxicity of carbon nanoparticles in humans in the new millennium: A systemic review |
Q38245148 | Upconverting nanoparticles: assessing the toxicity |
Q47413180 | Weight of evidence approach for the relative hazard ranking of nanomaterials |
Q36942217 | What do we (need to) know about the kinetic properties of nanoparticles in the body? |
Q37769176 | Workplace practices for engineered nanomaterial manufacturers |
Q37783304 | Zinc oxide nanoparticles in modern sunscreens: An analysis of potential exposure and hazard |
Q38832036 | [60]Fullerene-peptides: bio-nano conjugates with structural and chemical diversity |
Search more.